🎉 M&A multiples are live!
Check it out!

Orion Valuation Multiples

Discover revenue and EBITDA valuation multiples for Orion and similar public comparables like Galapagos, Vivoryon Therapeutics, and Armata Pharmaceuticals.

Orion Overview

About Orion

Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries, North America and other countries.


Founded

2006

HQ

Finland
Employees

3.7K+

Website

orion.fi

Financials

LTM Revenue $1.9B

LTM EBITDA $606M

EV

$11.0B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 12K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Orion Financials

Orion has a last 12-month revenue (LTM) of $1.9B and a last 12-month EBITDA of $606M.

In the most recent fiscal year, Orion achieved revenue of $1.8B and an EBITDA of $605M.

Orion expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Orion valuation multiples based on analyst estimates

Orion P&L

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $1.9B XXX $1.8B XXX XXX XXX
Gross Profit $1.0B XXX $1.1B XXX XXX XXX
Gross Margin 53% XXX 61% XXX XXX XXX
EBITDA $606M XXX $605M XXX XXX XXX
EBITDA Margin 32% XXX 33% XXX XXX XXX
EBIT $511M XXX $488M XXX XXX XXX
EBIT Margin 27% XXX 27% XXX XXX XXX
Net Profit $404M XXX $389M XXX XXX XXX
Net Margin 21% XXX 21% XXX XXX XXX
Net Debt XXX XXX $131M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Orion Stock Performance

As of July 16, 2025, Orion's stock price is EUR 66 (or $78).

Orion has current market cap of EUR 9.3B (or $10.9B), and EV of EUR 9.3B (or $11.0B).

See Orion trading valuation data

Orion Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$11.0B $10.9B XXX XXX XXX XXX $2.88

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Orion Valuation Multiples

As of July 16, 2025, Orion has market cap of $10.9B and EV of $11.0B.

Orion's trades at 6.0x EV/Revenue multiple, and 18.2x EV/EBITDA.

Equity research analysts estimate Orion's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Orion has a P/E ratio of 27.0x.

See valuation multiples for Orion and 12K+ public comps

Orion Financial Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $10.9B XXX $10.9B XXX XXX XXX
EV (current) $11.0B XXX $11.0B XXX XXX XXX
EV/Revenue 5.8x XXX 6.0x XXX XXX XXX
EV/EBITDA 18.1x XXX 18.2x XXX XXX XXX
EV/EBIT 21.5x XXX 22.5x XXX XXX XXX
EV/Gross Profit 11.0x XXX n/a XXX XXX XXX
P/E 27.0x XXX 28.1x XXX XXX XXX
EV/FCF 31.7x XXX 45.2x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Orion Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Orion Margins & Growth Rates

Orion's last 12 month revenue growth is 13%

Orion's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.2M for the same period.

Orion's rule of 40 is 41% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Orion's rule of X is 65% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Orion and other 12K+ public comps

Orion Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 13% XXX 13% XXX XXX XXX
EBITDA Margin 32% XXX 33% XXX XXX XXX
EBITDA Growth 17% XXX 23% XXX XXX XXX
Rule of 40 41% XXX 47% XXX XXX XXX
Bessemer Rule of X XXX XXX 65% XXX XXX XXX
Revenue per Employee XXX XXX $0.5M XXX XXX XXX
Opex per Employee XXX XXX $0.2M XXX XXX XXX
S&M Expenses to Revenue XXX XXX 18% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 12% XXX XXX XXX
Opex to Revenue XXX XXX 34% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Orion Public Comps

See public comps and valuation multiples for Biopharmaceuticals and Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
Armata Pharmaceuticals XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Orion M&A and Investment Activity

Orion acquired  XXX companies to date.

Last acquisition by Orion was  XXXXXXXX, XXXXX XXXXX XXXXXX . Orion acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Orion

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Start Free Trial

About Orion

When was Orion founded? Orion was founded in 2006.
Where is Orion headquartered? Orion is headquartered in Finland.
How many employees does Orion have? As of today, Orion has 3.7K+ employees.
Who is the CEO of Orion? Orion's CEO is Ms. Liisa Hurme, PhD.
Is Orion publicy listed? Yes, Orion is a public company listed on HEL.
What is the stock symbol of Orion? Orion trades under ORNAV ticker.
When did Orion go public? Orion went public in 2006.
Who are competitors of Orion? Similar companies to Orion include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics.
What is the current market cap of Orion? Orion's current market cap is $10.9B
What is the current revenue of Orion? Orion's last 12 months revenue is $1.9B.
What is the current revenue growth of Orion? Orion revenue growth (NTM/LTM) is 13%.
What is the current EV/Revenue multiple of Orion? Current revenue multiple of Orion is 5.8x.
Is Orion profitable? Yes, Orion is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Orion? Orion's last 12 months EBITDA is $606M.
What is Orion's EBITDA margin? Orion's last 12 months EBITDA margin is 32%.
What is the current EV/EBITDA multiple of Orion? Current EBITDA multiple of Orion is 18.1x.
What is the current FCF of Orion? Orion's last 12 months FCF is $347M.
What is Orion's FCF margin? Orion's last 12 months FCF margin is 18%.
What is the current EV/FCF multiple of Orion? Current FCF multiple of Orion is 31.7x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.